ProImmune launches ProVE SL self-loading MHC Class I monomers to improve T cell research flexibility: Oxford, England Saturday, November 1, 2025, 14:00 Hrs [IST] ProImmune Ltd, a ...

This insightful review explores key areas of cancer genetic research, focusing on genes that may benefit from ...

ProImmune Ltd, a global leader in life science reagents and services, today announced the launch of its new ProVE® SL Self-Loading MHC Class I Monomers. The novel reagents for antigen-specific CD8+ T ...

This important study provides a systematic investigation of parent-of-origin (POE) effects on gene expression using large trio-based data from the Framingham Heart Study, uncovering thousands of ...

Jared Abbott, the director of the Center for Working-Class Politics, discusses what it would take for Democrats to better ...

Research from UChicago dissects how a single genetic switch helps butterflies mimic wing patterns of other species to protect ...

ProImmune has announced the launch of its ProVE SL Self-Loading MHC Class I Monomers, a new reagent platform designed to enhance antigen-specific CD8+ T cell detection. The Oxford-based life science ...

A newly identified genetic marker may significantly improve the ability to predict life-threatening reactions to the gout ...

New research posits that a genetic incompatibility between female offspring of humans and Neanderthals and their children ...

Using a new time-resolved Mendelian randomization approach in over 360,000 UK Biobank participants, Karlsson et al. revealed ...